Search
for

    GlossaryNitric Oxide Synthase (NOS)

    enzyme producing nitric oxide for blood vessel dilation and more

    Nitric Oxide Synthase (NOS) is an enzyme responsible for producing nitric oxide, a molecule that plays a crucial role in various physiological processes, including blood vessel dilation, immune response, and neurotransmission. There are three main types of NOS: endothelial (eNOS), neuronal (nNOS), and inducible (iNOS), each serving different functions in the body.

    Related Terms

    Learn

    0 / 0 results
    — no results

    Research

    5 / 1000+ results

    Community Join

    5 / 368 results

      community 1 Year on 1x 1mg Fin & 2x 5% Topical Min Daily

      in Is this regrowth?  16 upvotes 2 years ago
      Regrowth from using a regimen of finasteride and topical minoxidil daily, with additional microneedling since January 2023, as well as intermittent usage of nizoral and biotin tablets. The replies suggest that the user has seen positive results in their hairline.

      community Fin/min/derma/niz 8 month update

      in Progress Pictures 3 years ago
      Hair loss treatments, including the use of Minoxidil and Finasteride, with a user sharing their 8-month update on progress made. Others have chimed in to provide encouragement and advice for continued treatment.

      community 1 year of min+fin+ketoconazole

      in Progress Pictures  1058 upvotes 1 year ago
      The user has been using minoxidil daily, finasteride three times a week, and ketoconazole 1-3 times a week for a year to treat hair loss, resulting in noticeable hair regrowth at the hairline and temples, with minor side effects like itching and dandruff. They started with minoxidil a month before the other treatments and experienced an initial shedding phase for about six weeks.

      community Pp405 phase 2a clinical results

      in Research/Science  38 upvotes 8 months ago
      PP405 shows initial promise for treating androgenetic alopecia, with safety confirmed in early trials, but skepticism remains due to limited data. Further trials are needed to determine its true efficacy and potential market impact.